Stem cell therapy of myocarditis and cardiomyopathies: a promising strategy
Cell and Organ Transplantology · 2022
DOI: 10.22494/cot.v10i2.140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell and Organ Transplantology, 2022. Verfasst von V. Kovalenko und 3 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
The literature review is devoted to the analysis of modern data on the effectiveness of stem cell transplantation in patients with non-coronary heart diseases: myocarditis, dilated cardiomyopathy, and systemic amyloidosis with heart damage. The results of experimental studies on laboratory animals and clinical trials concerning the use of various types of stem cells, their mechanisms of action and prospects for application in non-coronary heart diseases are presented. Emphasis is placed on the need for further randomized multicenter clinical trials, especially in patients with inflammatory myocardial injury, involving a large number of patients.
Zitieren
APA
Kovalenko, V., Nesukay, E., Cherniuk, S., & Kozliuk, A. (2022). Stem cell therapy of myocarditis and cardiomyopathies: a promising strategy. Cell and Organ Transplantology. https://doi.org/10.22494/cot.v10i2.140
Vancouver
Kovalenko V, Nesukay E, Cherniuk S, Kozliuk A. Stem cell therapy of myocarditis and cardiomyopathies: a promising strategy. Cell and Organ Transplantology. 2022. doi:10.22494/cot.v10i2.140
BibTeX
@article{Kovalenko2022,
author = {Kovalenko, V. and Nesukay, E. and Cherniuk, S. and Kozliuk, A.},
title = {Stem cell therapy of myocarditis and cardiomyopathies: a promising strategy},
journal = {Cell and Organ Transplantology},
year = {2022},
doi = {10.22494/cot.v10i2.140}
}
EUVIMED